share_log

Profound Medical Analyst Ratings

Profound Medical Analyst Ratings

深厚的醫學分析師評級
Benzinga Analyst Ratings ·  2022/11/04 14:57
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/04/2022 Raymond James Upgrades Outperform → Strong Buy
03/07/2022 207.69% Cowen & Co. $28 → $14 Maintains Outperform
02/22/2022 405.49% Raymond James $28 → $23 Downgrades Strong Buy → Outperform
09/15/2020 Jefferies Initiates Coverage On → Buy
09/10/2020 383.52% Lake Street → $22 Initiates Coverage On → Buy
04/01/2020 229.67% Cowen & Co. → $15 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
11/04/2022 雷蒙德·詹姆斯 升級 跑贏→強勢買入
03/07/2022 207.69% 考恩公司 $28 → $14 維護 跑贏大盤
02/22/2022 405.49% 雷蒙德·詹姆斯 $28 → $23 評級下調 強勢買入→跑贏大盤
09/15/2020 傑富瑞 開始承保 →購買
09/10/2020 383.52% 萊克街 → $22 開始承保 →購買
04/01/2020 229.67% 考恩公司 → $15 開始承保 →跑贏大盤

Profound Medical Questions & Answers

深奧的醫學問題與答案

What is the target price for Profound Medical (PROF)?
深奧醫療(教授)的目標價是多少?

The latest price target for Profound Medical (NASDAQ: PROF) was reported by Raymond James on November 4, 2022. The analyst firm set a price target for $0.00 expecting PROF to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

深奧醫療(納斯達克:PRO)的最新目標價是由Raymond James於2022年11月4日報道的。這家分析公司將目標價定為0.00美元,預計Prof將在12個月內下跌(跌幅可能為-100.00%)。3家分析公司在過去一年公佈了評級。

What is the most recent analyst rating for Profound Medical (PROF)?
深奧醫療(教授)的最新分析師評級是多少?

The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Raymond James, and Profound Medical upgraded their strong buy rating.

深奧醫療(納斯達克:PROF)的最新分析師評級由Raymond James提供,深奧醫療上調了其強力買入評級。

When is the next analyst rating going to be posted or updated for Profound Medical (PROF)?
深奧醫療(教授)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on November 4, 2022 so you should expect the next rating to be made available sometime around November 4, 2023.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閲公共財務報表,與深奧醫療的高管和客户交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。深奧醫療的上一次評級是在2022年11月4日提交的,所以你應該預計下一次評級將在2023年11月4日左右的某個時候提供。

Is the Analyst Rating Profound Medical (PROF) correct?
分析師對深奧醫療(教授)的評級正確嗎?

While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a upgraded with a price target of $0.00 to $0.00. The current price Profound Medical (PROF) is trading at is $4.55, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的深遠醫療(教授)評級被上調,目標價從0.00美元到0.00美元。深奧醫療(教授)目前的交易價格為4.55美元,超出了分析師的預測範圍。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論